IL-6 is also reported to increase prostaglandin productions from AECs and often referred in the literature as a “causal factor” for various adverse outcomes, specifically infection and inflammation associated PTB and pPROM (Romero et al., 1990; Santhanam et al., 1991). This evidence concerns the gene IL6 and preterm premature rupture of the membranes.